Press Releases

# results: 181-195 of 207
Show items per page
Date Press Releases Topic
Jun 19, 2007

Ten Scientists Named 2007 Pew Latin American Fellows in the Biomedical Sciences

The Pew Charitable Trusts and the University of California at San Francisco (UCSF) announced today that ten promising biomedical scientists have been named 2007 Pew Latin American Fellows in the Biomedical Sciences.

More

Biomedical Research
May 10, 2007

Final Pew Initiative Report Examines Status of Research on Functional Foods and Regulations They Will Face

Researchers are using biotechnology to enhance nutritional and other properties of food for consumer benefit, but such products will face a complicated array of review requirements before they can come on the market, according to Application of Biotechnology for Functional Foods, a final new report released today by the Pew Initiative on Food and Biotechnology.

More

Food Safety
Apr 25, 2007

Publication Announcement: U.S. Public Opinion on Uses of Genetic Information and Genetic Discrimination

While Americans are generally very supportive of the use of genetic information to improve their own health and the health of their families, 92 percent are wary that this same information could be used in ways that harm them, according to a public opinion survey by the Genetics and Public Policy Center conducted in late February and early March of this year.

More

Mar 27, 2007

Conference Proceedings on Emerging Challenges for Biotech Specialty Crops, Now Available from the Pew Initiative on Food and Biotechnology, APHIS

Biotech specialty crops—fruits and vegetables, tree nuts and nursery crops—face unique regulatory challenges, but there are opportunities to improve the regulatory system to help support this important sector of the U.S. agricultural economy, according to participants at a recent workshop, co-sponsored by the Pew Initiative on Food and Biotechnology and the Animal and Plant Health Inspection Service (APHIS).

More

Food Safety
Mar 7, 2007

New Report on Moral and Ethical Issues Related to GE Food Animals From the Pew Initiative on Food and Biotechnology, Michigan State University

Many public discussions about cloned and genetically engineered (GE) food animals have focused on questions of the regulatory authorities that may govern such animals, but few have considered the impacts of ethical or moral concerns. While ethical issues can be equally as or even more important than safety and regulatory issues to many people, there is currently no established venue where these issues can be fully addressed, according to some of the experts who gathered at a workshop last October sponsored by the Pew Initiative on Food and Biotechnology and Michigan State University.

More

Food Safety
Feb 12, 2007

New Campaign Champions Changes in Medical Prescribing to End Conflicts of Interest

The Prescription Project called on academic medical centers, professional medical societies and public and private payers to end conflicts of interest resulting from the $12 billion spent annually on pharmaceutical marketing.

More

Conflicts of Interest
Feb 8, 2007

New Conference Proceedings Examine Genetically Engineered Food and Feed Imports, Implications For U.S. Domestic Policies

In September 2006, the Pew Initiative on Food and Biotechnology held a workshop in Washington, D.C., examining issues related to the potential importation into the U.S. of new varieties of genetically engineered (GE) crops and the various implications this could have on the U.S. regulatory system and food industry.

More

Food Safety
Jan 25, 2007

Pew Initiative on Food and Biotechnology to Conclude Its Work

The Pew Initiative on Food and Biotechnology will conclude its work at the end of March 2007. Established by The Pew Charitable Trusts in 2001, the project has achieved its goals of illuminating policy issues arising from advances in ag biotech and serving as a credible “honest broker” that could bring together stakeholders of differing views to discuss the opportunities and challenges that ag biotech presents.

More

Food Safety
Dec 12, 2006

Report Finds U.S. Bioterror, Bird Flu, and Health Disaster Preparedness Inadequate

Trust for America’s Health (TFAH) today released the fourth annual Ready or Not? Protecting the Public’s Health from Disease, Disasters, and Bioterrorism report, which found that five years after the September 11th and anthrax tragedies, emergency health preparedness is still inadequate in America. The Ready or Not? report contains state-by-state health preparedness scores based on 10 key indicators to assess health emergency preparedness capabilities. All 50 U.S. states and the District of Columbia were evaluated. Half of states scored six or less on the scale of 10 indicators. Oklahoma scored the highest with 10 out of 10; California, Iowa, Maryland, and New Jersey scored the lowest with four out of 10. States with stronger surge capacity capabilities and immunization programs scored higher in this year’s report, since four of the measures focus on these areas.

 

More

Oct 16, 2006

New Initiative Will Help State and Local Health Agencies Prepare for Pandemic Flu

State and local health departments will soon get additional help preparing for a potential pandemic influenza through a partnership announced today between The Pew Charitable Trusts and the Center for Infectious Disease Research and Policy (CIDRAP) at the University of Minnesota.The project, a complement to the Trusts’ Pandemic Preparedness Initiative launched earlier this year, will identify the most problematic issues state and local agencies may confront in a pandemic, and then, by summer of 2007, collect and widely disseminate innovations and options for addressing them.

More

Oct 5, 2006

Statement of Rebecca W. Rimel on the News That a Pew Scholar in the Biomedical Sciences Won the 2006 Nobel Prize in Medicine

"The Pew Charitable Trusts extends our warmest congratulations to Craig C. Mello, Ph.D., on his achievement in winning the Nobel Prize in Medicine. Dr. Mello was selected in 1995 as a Pew Scholar in the Biomedical Sciences, receiving support over four years for his research on RNA interference - an investigation that ultimately led to his award-winning discovery..."

More

Biomedical Research
Sep 27, 2006

Lax Oversight of Genetic Tests

Better oversight of genetic testing laboratories by the Centers for Medicare and Medicaid Services (CMS) is “critical to ensuring the quality of genetic testing in the United States,” and failure to provide it “poses a risk to the public’s health,” according to a Petition for Rulemaking submitted today to CMS Administrator Mark McClellan by the Genetics and Public Policy Center, Public Citizen, and Genetic Alliance.

More

Aug 8, 2006

Improvement Needed in Genetic Testing Oversight

In recent months many health-related organizations have joined in calling on the Centers for Medicare and Medicaid Services (CMS) to end years of delay in assuring the safety and accuracy of genetic testing. In separate letters to CMS Administrator Mark McClellan, members of Genetic Alliance and a coalition of women’s health groups urged the agency to issue a proposed rule to create a genetic testing specialty under the Clinical Laboratory Improvement Amendments (CLIA) of 1988.

More

Aug 4, 2006

New Bill Could Jumpstart The Setting of Sound Genetic Public Policy

Sen. Barack Obama (D-IL) introduced legislation to improve development and appropriate use of genetic tests in the United States, the Genetics and Public Policy Center has learned. "The Obama bill accelerates advances in the beneficial applications of genetic technologies to human health, while ensuring appropriate safeguards for the quality of genetic testing," says Center Director Kathy Hudson.

More

Jul 27, 2006

Oversight Gaps for Genetic Testing Pose Risks to Public Health

At the invitation of the Senate Special Committee on Aging, Genetics and Public Policy Center Director Kathy Hudson testified on Thursday, July 27 as part of the hearing "At Home DNA Tests: Marketing Scam or Medical Breakthrough?" Hudson made the case that poor oversight of genetic testing has led to a situation in which "there is no way for a consumer to distinguish between the dubious and the decent" genetic tests and the laboratories that perform them.

More